P. Veronesi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
P Veronesi, P. Veronesi, Paolo Veronesi
Publication record
452 papers · 25,424 citations · H-index 77

PAPERS

Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients
20230 citationsauthor #10
Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis
20237 citationsauthor #3
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
20236 citationsauthor #10
Metaplastic breast cancer: an all-round multidisciplinary consensus
202312 citationsauthor #23
A narrative review for radiation oncologists to implement preoperative partial breast irradiation
20237 citationsauthor #22
LONG-TERM OUTCOMES AFTER BREAST CONSERVING SURGERY PLUS WHOLE BREAST IRRADIATION VS MASTECTOMY IN BREAST CANCER: A PROPENSITY SCORE–MATCHED STUDY
20230 citationsauthor #10
Abstract P6-02-11: Implementation of multigene panel testing in triple-negative breast cancer. The PERSONA-breast trial
20230 citationsauthor #7
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
20239 citationsauthor #9
Robot-assisted mastectomy: next major advance in breast cancer surgery.
202313 citationsauthor #17
Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis
202324 citationsauthor #6
P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers
20230 citationsauthor #8
Abstract P2-21-04: The tumor immune microenvironment composition and prognostic value in breast cancer during pregnancy is dynamic during the gestation period
20230 citationsauthor #10
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
202311 citationsauthor #13
PO-1253 Single fraction ablative preoperative RT for early-stage BC, the CRYSTAL trial: preliminary results
20230 citationsauthor #22
Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women
20235 citationsauthor #3
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
202319 citationsauthor #8
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature.
20237 citationsauthor #6
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes
2023331 citationsauthor #30
The Effect of Adjuvant Radiotherapy on One- and Two-Stage Prosthetic Breast Reconstruction and on Autologous Reconstruction: A Multicenter Italian Study among 18 Senonetwork Breast Centres
202312 citationsauthor #13
Low-risk triple-negative breast cancers: clinico-pathological and molecular features.
202226 citationsauthor #9
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer
202234 citationsauthor #26
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study – a phase I/II clinical trial protocol
20220 citationsauthor #20
Malignant phyllodes tumor of the breast: a systematic review
202253 citationsauthor #8
“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”
202227 citationsauthor #9
ASO Visual Abstract: Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery: A Rare Complication and a Proposed Management Strategy from the British and Italian Experience
20221 citationsauthor #5
185P Prospective study to evaluate pathological complete response after neoadjuvant therapy in breast cancer: Are we ready to avoid surgery?
20220 citationsauthor #9
114P Axillary management in elderly women (≥70 years) with breast cancer: 10-years follow-up
20220 citationsauthor #7
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.
20222 citationsauthor #6
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study – a phase I/II clinical trial protocol
202212 citationsauthor #20
Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience
20229 citationsauthor #25
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
20226 citationsauthor #14
A propensity score–matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer
202212 citationsauthor #10
CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study
20224 citationsauthor #6
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center
20229 citationsauthor #15
PO-1190 Machine learning to predict locoregional relapse in pT1-2pN0-1 breast cancer following mastectomy
20220 citationsauthor #18
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study
20229 citationsauthor #22
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
20227 citationsauthor #9
Assessing variability in breast cancer management across the world: results of a questionnaire survey amongst global international experts in breast cancer management
20222 citationsauthor #20
Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery
202210 citationsauthor #3
Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery—A Rare Complication and a Proposed Management Strategy from the British and Italian Experience
20223 citationsauthor #5
Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer
20226 citationsauthor #3
Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer
20223 citationsauthor #8
22P Biobanking in breast cancer: 10 years of practice at the European Institute of Oncology
20220 citationsauthor #11
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
202220 citationsauthor #12
A New Level II Oncoplastic Technique for Inferior Pole Defects: The Three-Petal Glandular Reconstruction (3-PR)
20222 citationsauthor #9
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature
20228 citationsauthor #10
Abstract P4-07-02: Tumor microenvironment characteristics and prognosis in breast cancer during pregnancy: The role of differentially expressed immune-related genes
20220 citationsauthor #10
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique
20227 citationsauthor #16
Abstract P3-18-08: Feasibility and safety of breast-conserving surgery in early-stage breast cancers during the first trimester of pregnancy
20220 citationsauthor #15
Postmastectomy breast reconstruction for women with hereditary gastric and breast cancer syndrome
20224 citationsauthor #6
ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres
20220 citationsauthor #5
A randomized presurgical trial of alternative dosing of exemestane in postmenopausal women with early-stage ER-positive breast cancer.
20222 citationsauthor #8
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL
202246 citationsauthor #4
Advances and controversies in management of breast ductal carcinoma in situ (DCIS).
202128 citationsauthor #17
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
20214 citationsauthor #11
PO-1097 Preclinical evaluation for dose escalation in the preoperative SBRT of early breast cancer
20210 citationsauthor #6
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
202112 citationsauthor #17
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients
20214 citationsauthor #14
Predictors of positive axillary non-sentinel lymph nodes in breast cancer patients with positive sentinel lymph node biopsy after neoadjuvant systemic therapy.
202113 citationsauthor #19
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study.
20218 citationsauthor #10
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis
202123 citationsauthor #13
A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation
202169 citationsauthor #23
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
202113 citationsauthor #8
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
20217 citationsauthor #6
Ten‐year outcome results of cT4 breast cancer after neoadjuvant treatment
20215 citationsauthor #8
Is Nipple-Sparing Mastectomy Indicated after Previous Breast Surgery? A Series of 387 Institutional Cases
20215 citationsauthor #9
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review
202124 citationsauthor #10
CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome
202112 citationsauthor #8
Frequency of CDH1 Germline Mutations in Non-Gastric Cancers
202111 citationsauthor #5
Is Mastectomy a Suitable Treatment in Ductal Carcinoma In Situ?
20212 citationsauthor #1
Schwannoma of the axillary region. Imaging findings, clinical pitfalls, and misdiagnosis
20213 citationsauthor #10
Multimodal treatment of colorectal postsurgical leaks: long-term results of the over-thescope clip (OTSC) application.
20211 citationsauthor #4
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
2021148 citationsauthor #6
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study
202121 citationsauthor #10
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial
202110 citationsauthor #24
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients
202110 citationsauthor #12
CDH1 germline mutations in families with hereditary lobular breast cancer
202121 citationsauthor #6
Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients.
202111 citationsauthor #11
ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy
20210 citationsauthor #4
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
202171 citationsauthor #20
Management of breast cancer patients during the peak of the COVID 19 pandemic
20212 citationsauthor #20
Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology.
20217 citationsauthor #14
PH-0219 Ten-year results of hypofractionated whole breast RT and intraoperative boost in premenopausal women
20210 citationsauthor #9
ASO Visual Abstract: Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: is it Oncologically Safe? A Retrospective Matched-Cohort Analysis
20210 citationsauthor #13
Evaluation of the impact of the COVID-19 pandemic on the practice of axillary node dissection
20210 citationsauthor #14
Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: pooled analysis of individual patient-level data from international multi-centers
20210 citationsauthor #11
Is metaplastic breast cancer more aggressive than “classic” triple-negative ductal carcinoma? Recent prognostic and therapeutic consideration
20210 citationsauthor #3
ASO Visual Abstract: How to Safely Perform Repeat Sentinel Node Biopsy After a Previous Mastectomy—Technical Features and Oncological Outcomes
20210 citationsauthor #12
Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast‐conserving surgery?
20213 citationsauthor #3
Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated
20218 citationsauthor #16
Breast Cancer Surgery: New Issues
202116 citationsauthor #6
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes
202112 citationsauthor #12
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction.
20213 citationsauthor #14
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons.
20211 citationsauthor #6
Feasibility and surgical impact of Z0011 trial criteria application: The experience of the European institute of oncology
20201 citationsauthor #4
Axillary surgery in breast cancer: evolution and de-escalation.
20200 citationsauthor #1
Axillary surgery in breast cancer: An updated historical perspective.
202093 citationsauthor #6
COVID-19: The European institute of oncology as a “hub” centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month
202020 citationsauthor #6
Fine Needle Biopsy Plus EUS-Guided Cholecystojejunostomy by LAMS With a Water-Filled Technique in a Patient With Roux-En-Y Reconstruction.
20206 citationsauthor #7
PO-0937: Partial breast re-irradiation with IMRT for local recurrence after whole breast radiotherapy
20200 citationsauthor #10

TIMELINE

1962 0 citations

1988 5 citations

1989 0 citations

1990 28 citations

1991 182 citations

1992 252 citations

1993 143 citations

1994 50 citations

1995 18 citations

1996 16 citations

1997 2,081 citations

1998 62 citations

1999 1,396 citations

2000 109 citations

2001 1,043 citations

2002 800 citations

2003 2,858 citations

2004 638 citations

2005 1,090 citations

2006 1,094 citations

2007 519 citations

2008 617 citations

2009 1,578 citations

2010 1,274 citations

2011 716 citations

2012 1,135 citations

2013 2,575 citations

2014 212 citations

2015 269 citations

2016 491 citations

2017 530 citations

2018 887 citations

2019 281 citations

2020 645 citations

2021 588 citations

2022 324 citations

2023 463 citations

Unknown 0 citations

P. Veronesi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT